Article
Position Of Biologics /Biosimilars /Biogenerics Products In India
When Stanley N. Cohen of Stanford and Herbert W. Boyer obtained a US patent in 1980 for the process for joining and replicating DNA from different species little they realized that they are ushering the era of Recombinant revolution for the entry of biologics as potential drugs or organic food products.
Lex Orbis